DBV Technologies (DBVT) FCF Margin (2020 - 2026)
DBV Technologies (DBVT) reported FCF Margin of 5500.0% for Q1 2026, down 303750.0% year-over-year from N/an in Q1 2025, and little changed quarter-over-quarter from 5511.01% in Q4 2025.
DBV Technologies (DBVT) FCF Margin (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of FCF Margin data on file, last reported at 5500.0% in Q1 2026.
- FCF Margin for Q1 2026 came in at 5500.0%, down 303750.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2619.52% (down 6633.0% YoY), and the FY2025 annual result was 2159.56%, up 41360.0% from the prior year.
- FCF Margin held at 5500.0% in Q1 2026 per DBVT's latest filing, from 5511.01% in the prior quarter.
- Over five years, FCF Margin peaked at 1832.59% in Q4 2022 and troughed at 5511.01% in Q4 2025.
- A 5-year average of 1769.25% and a median of 1173.47% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2025: FCF Margin jumped 250449 bps in 2022, then slumped 313782 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 1832.59% in 2022, then slumped by 109 bps to 158.17% in 2023, then slumped by 1400 bps to 2373.19% in 2024, then sank by 132 bps to 5511.01% in 2025, then advanced by 0 bps to 5500.0% in 2026.
- Business Quant data shows DBVT's FCF Margin at 5500.0% in Q1 2026, 5511.01% in Q4 2025, and 1173.47% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -5,500.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,500.00% |
| Dec 31, 2025 | -5,511.01% |
| Sep 30, 2025 | -1,173.47% |
| Jun 30, 2025 | -2,315.02% |
| Mar 31, 2025 | -2,462.50% |
| Dec 31, 2024 | -2,373.19% |
| Sep 30, 2024 | -2,131.81% |
| Jun 30, 2024 | -3,083.98% |
| Mar 31, 2024 | -2,560.55% |
| Dec 31, 2023 | -158.17% |
| Sep 30, 2023 | -827.28% |
| Jun 30, 2023 | -1,123.99% |
| Mar 31, 2023 | -954.97% |
| Dec 31, 2022 | 1,832.59% |
| Sep 30, 2022 | -984.62% |
| Jun 30, 2022 | -685.94% |
| Mar 31, 2022 | -63.39% |
| Dec 31, 2021 | -671.90% |
| Sep 30, 2021 | -1,733.64% |
| Jun 30, 2021 | -2,024.73% |